Panobinostat PK/PD profile in combination with bortezomib and dexamethasone in patients with relapsed and relapsed/refractory multiple myeloma

PURPOSE: Panobinostat, a potent pan-deacetylase inhibitor, improved progression-free survival (PFS) in patients with relapsed and refractory multiple myeloma when combined with bortezomib and dexamethasone in a phase 3 trial, PANORAMA-1. This study aims to explore exposure–response relationship for...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Song, Kuroda, Yoshiaki, Shibayama, Hirohiko, Hino, Masayuki, Tajima, Takeshi, Corrado, Claudia, Lin, Rong, Waldron, Edward, Binlich, Florence, Suzuki, Kenshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713719/
https://www.ncbi.nlm.nih.gov/pubmed/26494130
http://dx.doi.org/10.1007/s00228-015-1967-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713719/
https://www.ncbi.nlm.nih.gov/pubmed/26494130
http://dx.doi.org/10.1007/s00228-015-1967-z

Ejemplares similares